Key result
Common KCNQ1 variants linked to ~35% greater type 2 diabetes risk in Chinese Han populations.
Why the study?
Common variants in KCNQ1 have recently been reported to be associated with type 2 diabetes in East Asians, but their association in a Chinese Han population and underlying mechanisms needed examination.
Are common variants in KCNQ1 associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population?
Cohort (n=3,210)
Are common variants in KCNQ1 associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population?
Effect estimate: OR 1.33-1.36
p-value: p=≤0.0009
Common variants in the KCNQ1 gene are significantly associated with type 2 diabetes and impaired fasting glucose in the Chinese Han population, likely mediated by impaired beta-cell function.
KCNQ1 variants associated with T2D and IFG in Chinese Hans; extends East Asian reports but leaves causal inference and clinical utility open.
Common variants in KCNQ1 have recently been reported to be associated with type 2 diabetes in East Asians. We aimed to examine whether these common variants (rs2074196, rs2237892, rs2237895 and rs2237897) were also associated with type 2 diabetes in a population-based cohort of 3210 Chinese Hans and to explore the underlying mechanisms. The SNPs rs2237892, rs2237895 and rs2237897 were significantly associated with type 2 diabetes (OR: 1.33–1.36, P ≤ 0.0009), impaired fasting glucose (IFG) (OR: 1.16–1.19, P ≤ 0.0193) and combined IFG/type 2 diabetes (OR: 1.23–1.24, P ≤ 0.0004), and the corresponding population attributable risks of type 2 diabetes for the three SNPs were 32.5, 18.8 and 35.8%, respectively. However, rs2074196 showed a weak, but significant association with IFG (OR: 1.18 [1.04–1.33], P = 0.009) and combined IFG/type 2 diabetes (OR: 1.17 [1.05–1.30], P = 0.0053), as well as a trend toward association with type 2 diabetes (OR: 1.15 [0.98–1.35], P = 0.0882), suggesting a different pattern of association when compared with the other three SNPs. The four SNPs were all significantly associated with HOMA-B (P ≤ 0.042) while rs2237895 and rs22378897 also showed significant association with fasting glucose (P ≤ 0.012). Notably, the associations with type 2 diabetes were markedly attenuated after adjusting for HOMA-B (ORrs2237892: 1.33 [1.05–1.68], P = 0.018; ORrs2237895: 1.24 [1.00–1.54], P = 0.0524; ORrs2237897: 1.22[0.98–1.53], P = 0.09). Moreover, GCCC haplotype showed similar associations with type 2 diabetes (OR: 1.48 [1.17–1.85], P = 0.0008), IFG (OR: 1.32 [1.10–1.57], P = 0.0023), combined IFG/type 2 diabetes (OR: 1.37 [1.17–1.61], P = 8.7 × 10−5), and lower HOMA-B values (β = −4.41 ± 1.62, P = 0.006). These results suggest that KCNQ1 is a major type 2 diabetes gene in the Chinese Hans and it may confer type 2 diabetes risk by impaired β-cell function.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2009) conducted a cohort in Type 2 diabetes and impaired fasting glucose (n=3,210). Common variants in KCNQ1 (rs2237892, rs2237895, rs2237897) vs. Non-carriers / reference alleles was evaluated on Type 2 diabetes (OR 1.33-1.36, p=≤0.0009). Common KCNQ1 variants (rs2237892, rs2237895, rs2237897) were significantly associated with type 2 diabetes (OR 1.33-1.36, P≤0.0009) in a Chinese Han population.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: